Drug
Lum015
Lum015: highest development phase Phase 1/2, developed by Lumicell, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Lumicell, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| LUM015 NCT02584244 | Phase 1/2 | Colorectal Cancer |
Latest
No recent events.
Follow Lum015 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.